(Q48475665)

11 February 2018

title

Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice. (English)

1 reference

11 February 2018

0 references

1 reference

E Galea

1

1 reference

11 February 2018

D L Feinstein

series ordinal

2

1 reference

11 February 2018

P Lacombe

series ordinal

3

1 reference

11 February 2018

publication date

8 July 2006

1 reference

11 February 2018

published in

Diabetologia

1 reference

11 February 2018

volume

49

1 reference

11 February 2018

issue

9

1 reference

11 February 2018

page(s)

2153-2161

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00125-006-0326-0

exact match

0 references

cites work

Repression of IFN-gamma expression by peroxisome proliferator-activated receptor gamma.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0326-0

Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0326-0

Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-006-0326-0

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

12 December 2020

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

1 reference

12 December 2020

Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects

1 reference

12 December 2020

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

1 reference

12 December 2020

Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function

1 reference

12 December 2020

Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?

1 reference

12 December 2020

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

1 reference

12 December 2020

Alzheimer's disease-like cerebrovascular pathology in transforming growth factor-beta 1 transgenic mice and functional metabolic correlates

1 reference

12 December 2020

The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.

1 reference

12 December 2020

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.

1 reference

12 December 2020

Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly

1 reference

12 December 2020

Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities

1 reference

12 December 2020

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study

1 reference

12 December 2020

Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells.

1 reference

12 December 2020

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways

1 reference

12 December 2020

Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice

1 reference

12 December 2020

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

12 December 2020

Mitochondrial abnormalities in Alzheimer brain: mechanistic implications

1 reference

12 December 2020

Regulation of glucose transport by pioglitazone in cultured muscle cells

1 reference

12 December 2020

Importance of mitochondrial superoxide dismutase expression in insulin-producing cells for the toxicity of reactive oxygen species and proinflammatory cytokines.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia

1 reference

12 December 2020

Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised

1 reference

12 December 2020

Lactate: a preferred fuel for human brain metabolism in vivo

1 reference

12 December 2020

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

1 reference

12 December 2020

Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.

1 reference

12 December 2020

Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents

1 reference

12 December 2020

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease

1 reference

12 December 2020

Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo

1 reference

12 December 2020

Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion

1 reference

12 December 2020

Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes

1 reference

12 December 2020

Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain

1 reference

12 December 2020

Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes.

1 reference

12 December 2020

Abnormalities of mitochondrial enzymes in Alzheimer disease.

1 reference

12 December 2020

Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease.

1 reference

12 December 2020

Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes

1 reference

12 December 2020

Glucose and memory in mild senile dementia of the Alzheimer type

1 reference

12 December 2020

10.1007/S00125-006-0326-0

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

16830140

1 reference

11 February 2018